Related Experiment Video
Updated: May 16, 2026
07:22
Basophil Activation Test for Allergy Diagnosis
Published on: May 31, 2021
Honeybee venom immunotherapy: certainties and pitfalls.
M Beatrice Bilò1, Leonardo Antonicelli, Floriano Bonifazi
1Allergy Unit, Department of Immunology, Allergy & Respiratory Diseases, University Hospital Ospedali Riuniti di Ancona, Ancona, Italy. b.bilo@ospedaliriuniti.marche.it
Immunotherapy
|December 1, 2012
Summary
Honeybee venom allergy poses risks for severe reactions and reduced treatment effectiveness. Research focuses on improving venom immunotherapy (VIT) and understanding allergic beekeeper populations.
Area of Science:
- Allergy and Immunology
- Toxicology
- Apiculture Science
Background:
- Honeybees play a crucial agricultural role.
- Honeybee venom allergy presents diagnostic and immunotherapeutic challenges.
- Allergic reactions to honeybee stings can be severe.
Purpose of the Study:
- To examine honeybee venom allergy from epidemiology to treatment.
- To emphasize venom immunotherapy (VIT) and its challenges.
- To explore the potential of studying allergic beekeepers.
Main Methods:
- Review of epidemiological data on honeybee venom allergy.
- Analysis of diagnostic approaches for honeybee venom allergy.
- Evaluation of current and potential treatments, including VIT.
Main Results:
- Honeybee venom allergy is a risk factor for severe systemic reactions.
- VIT effectiveness can be diminished, with increased side effects and relapse rates.
- Existing strategies for reducing VIT side effects require improvement.
Conclusions:
- Further improvements are needed in managing honeybee venom allergy and VIT.
- Allergic beekeepers offer unique opportunities for research into allergy and immunotherapy mechanisms.
Related Concept Videos
00:42Cross-reactivity
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:06Allergic Reactions
Overview
01:36Humoral Immune Responses
Overview
01:30Allergic Reactions: Anaphylaxis
Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...